PS0 Germline ( present in every cell of the body ) mutations in RET-13 cause multiple endocrine neoplasia-17 type 2 , an inherited cancer-23 syndrome characterized by medullary thyroid carcinoma-29 , pheochromocytoma-31 , and hyperparathyroidism-34 .
5
[PHENOTYPE-thyroid carcinoma-29]	[GENOTYPE-RET-13]
[PHENOTYPE-neoplasia-17]	[GENOTYPE-RET-13]
[PHENOTYPE-pheochromocytoma-31]	[GENOTYPE-RET-13]
[PHENOTYPE-cancer-23]	[GENOTYPE-RET-13]
[PHENOTYPE-hyperparathyroidism-34]	[GENOTYPE-RET-13]
PS15 The frequency of pes cavus , scoliosis-7 , axonal sensory neuropathy-11 and areflexia-13 increased with the size of GAA1-19 , whereas some signs such as sphincter disturbances-27 , cerebellar atrophy on MRI , amyotrophy-34 , dysarthria-36 and decreased vibration sense were associated with increased duration of the disease .
3
[PHENOTYPE-neuropathy-11]	[GENOTYPE-GAA1-19]
[PHENOTYPE-areflexia-13]	[GENOTYPE-GAA1-19]
[PHENOTYPE-scoliosis-7]	[GENOTYPE-GAA1-19]
PS42 Taken together , these data suggest that early onset neuropathy-10 is caused by Myelin protein zero mutations that significantly disrupt the tertiary structure of Myelin protein zero-27 and thus interfere with Myelin protein-33 zero - mediated adhesion and myelin compaction .
1
[PHENOTYPE-neuropathy-10]	[GENOTYPE-Myelin protein zero mutations]
PS95 We recently described a homozygous frameshift mutation in the human leptin ( ob ) gene associated with undetectable serum leptin-20 and extreme obesity-23 in two individuals .
2
[PHENOTYPE-undetectable serum leptin-20]	[GENOTYPE-frameshift mutation in the human leptin ( ob ) gene]
[PHENOTYPE-obesity-23]	[GENOTYPE-frameshift mutation in the human leptin ( ob ) gene]
PS98 Partial deletions of Hsa21-4 were identified in three patients with developmental delay-12 , epilepsy-14 , microcephaly-16 , and distinctive manifestations .
3
[PHENOTYPE-microcephaly-16]	[GENOTYPE-Partial deletions of Hsa21-4]
[PHENOTYPE-developmental delay-12]	[GENOTYPE-Partial deletions of Hsa21-4]
[PHENOTYPE-epilepsy-14]	[GENOTYPE-Partial deletions of Hsa21-4]
PS104 Mutations in the SLC22A12 gene-5 , which encodes a uric acid transporter , URAT1-14 , are associated with renal hypouricaemia-20 .
1
[PHENOTYPE-renal hypouricaemia-20]	[GENOTYPE-SLC22A12 gene-5]
PS111 Presence of a CRP4 A - allele-7 was associated with systemic lupus erythematosus nephritis-14 ( P < 0 . 01 ) and inversely correlated with arthritis-26 ( P < 0 . 01 ) , when comparing within the systemic lupus erythematosus group .
2
[PHENOTYPE-systemic lupus erythematosus nephritis-14]	[GENOTYPE-CRP4 A - allele-7]
[PHENOTYPE-arthritis-26]	[GENOTYPE-CRP4 A - allele-7]
PS143 Higher Insulin - like growth factor 1-7 circulating levels significantly increased 15 % of cancer-15 risk ( odds ratio ( OR ) , 1 . 15 , 95 % confidence interval ( CI ) , 1 . 03 - 1 . 29 ) , especially among prostate , pre - menopausal breast-52 and colorectal cancer-55 patients , whereas higher concentrations of IGF - binding protein 3-66 significantly decreased the risk of advanced prostate cancer-74 by 56 % ( OR , 0 . 44 , 95 % CI , 0 . 25 - 0 . 77 ) .
5
[PHENOTYPE-prostate]	[GENOTYPE-Insulin - like growth factor 1-7]
[PHENOTYPE-colorectal cancer-55]	[GENOTYPE-Insulin - like growth factor 1-7]
[PHENOTYPE-prostate cancer-74]	[GENOTYPE-IGF - binding protein 3-66]
[PHENOTYPE-pre - menopausal breast-52]	[GENOTYPE-Insulin - like growth factor 1-7]
[PHENOTYPE-cancer-15]	[GENOTYPE-Insulin - like growth factor 1-7]
PS195 The study was designed to examine the effect on clinical expression of rheumatoid arthritis-14 of HLA alleles-17 , particularly DR4-20 and DR1-22 that contain susceptibility sequences for rheumatoid arthritis-29 in the third hypervariable region ( HVR3 ) of HLA - DRB1-41 .
8
[PHENOTYPE-rheumatoid arthritis-29]	[GENOTYPE-HLA alleles-17]
[PHENOTYPE-rheumatoid arthritis-29]	[GENOTYPE-DR4-20]
[PHENOTYPE-rheumatoid arthritis-14]	[GENOTYPE-DR1-22]
[PHENOTYPE-rheumatoid arthritis-14]	[GENOTYPE-HLA alleles-17]
[PHENOTYPE-rheumatoid arthritis-29]	[GENOTYPE-DR1-22]
[PHENOTYPE-rheumatoid arthritis-14]	[GENOTYPE-DR4-20]
[PHENOTYPE-rheumatoid arthritis-14]	[GENOTYPE-( HVR3 ) of HLA - DRB1-41]
[PHENOTYPE-rheumatoid arthritis-29]	[GENOTYPE-( HVR3 ) of HLA - DRB1-41]
PS217 The genetic control of sex and HLA - B8-9 , DR3-11 of serum IgA-14 levels could be related to the high incidence of autoimmune disorders-25 among females and HLA - B8-31 , DR3-33 - positive individuals .
5
[PHENOTYPE-autoimmune disorders-25]	[GENOTYPE-serum IgA-14]
[PHENOTYPE-autoimmune disorders-25]	[GENOTYPE-HLA - B8-31]
[PHENOTYPE-autoimmune disorders-25]	[GENOTYPE-DR3-11]
[PHENOTYPE-autoimmune disorders-25]	[GENOTYPE-DR3-33]
[PHENOTYPE-autoimmune disorders-25]	[GENOTYPE-HLA - B8-9]
PS232 Congenital hyperinsulinism-2 is characterized by persistent hypoglycemia-7 due to the inappropriate insulin-12 secretion .
2
[PHENOTYPE-Congenital hyperinsulinism-2]	[GENOTYPE-insulin-12]
[PHENOTYPE-hypoglycemia-7]	[GENOTYPE-insulin-12]
PS266 The RET proto - oncogene-5 is responsible for medullary thyroid cancer-11 and multiple endocrine neoplasia-15 type 2 .
2
[PHENOTYPE-neoplasia-15]	[GENOTYPE-RET proto - oncogene-5]
[PHENOTYPE-thyroid cancer-11]	[GENOTYPE-RET proto - oncogene-5]
PS271 Frequent inactivation of DMBT1-4 contrasting with rare mutations of PTEN-10 may indicate that DMBT1-14 is preferentially involved in oligodendrogliomas-19 .
2
[PHENOTYPE-oligodendrogliomas-19]	[GENOTYPE-DMBT1-4]
[PHENOTYPE-oligodendrogliomas-19]	[GENOTYPE-DMBT1-14]
PS321 Loss - of - function mutations of the MECP2 gene-10 at Xq28-12 are associated with Rett syndrome in females and with syndromic and nonsyndromic forms of mental retardation-28 in males .
1
[PHENOTYPE-mental retardation-28]	[GENOTYPE-Loss - of - function mutations of the MECP2 gene-10 at Xq28-12]
PS324 Anhidrotic ectodermal dysplasia-3 is caused by mutations in the ectodermal dysplasia-11 gene encoding ectodysplasin A-15 , a member of the TNF ligand superfamily-23 involved in the communication between the cells .
2
[PHENOTYPE-Anhidrotic ectodermal dysplasia-3]	[GENOTYPE-ectodysplasin A-15]
[PHENOTYPE-ectodermal dysplasia-11]	[GENOTYPE-ectodysplasin A-15]
PS328 Mutation screening and analysis in hypertrophic cardiomyopathy-7 family could therefore facilitate the early hypertrophic cardiomyopathy diagnosis and would be helpful for the prediction , prevention and early treatment of hypertrophic cardiomyopathy-31 linked with MYH7 gene-35 mutation .
1
[PHENOTYPE-hypertrophic cardiomyopathy-31]	[GENOTYPE-MYH7 gene-35]
PS368 Unlike mutations in the beta - myosin heavy chain gene-10 , the prognostic significance of which reflect their hypertrophic expressivity , cardiac troponinT mutations are associated with a mild degree of hypertrophy-32 , but a high incidence of sudden cardiac death-41 .
2
[PHENOTYPE-sudden cardiac death-41]	[GENOTYPE-troponinT mutations]
[PHENOTYPE-hypertrophy-32]	[GENOTYPE-troponinT mutations]
PS388 The only infant with the deletion of 3 alpha - globin-11 structural genes had 25 % hemoglobin Bart ' s associated with a moderate microcytic anemia-26 at birth and developed the clinical picture of hemoglobin H disease-37 .
2
[PHENOTYPE-hemoglobin H disease-37]	[GENOTYPE-deletion of 3 alpha - globin-11]
[PHENOTYPE-anemia-26]	[GENOTYPE-deletion of 3 alpha - globin-11]
PS398 MECP2-1 has also been implicated in variable mental retardation-9 phenotypes , including X - linked Mental Retardation-17 , Fragile - X-21 - like Syndrome and Angelman - like ( AS ) phenotypes .
2
[PHENOTYPE-Mental Retardation-17]	[GENOTYPE-MECP2-1]
[PHENOTYPE-mental retardation-9]	[GENOTYPE-MECP2-1]
PS405 We found significant correlations between germline CDKN2A mutations and melanoma-10 and between dysplastic naevus-14 syndrome phenotype and melanoma-18 , respectively .
1
[PHENOTYPE-melanoma-10]	[GENOTYPE-germline CDKN2A mutations]
PS414 Mutations in inhibitory GABAA receptor subunit genes ( GABRA1-9 , GABRB3-11 , GABRG2-13 and GABRD-15 ) have been associated with idiopathic epilepsy syndromes including childhood absence epilepsy , juvenile myoclonic epilepsy , pure febrile seizures-35 , generalized epilepsy-38 with febrile seizures-41 plus ( GEfebrile seizures-45 + ) , and Dravet syndrome ( also known as severe myoclonic epilepsy in infancy , SMEI ) .
16
[PHENOTYPE-generalized epilepsy-38]	[GENOTYPE-GABRA1-9]
[PHENOTYPE-generalized epilepsy-38]	[GENOTYPE-GABRD-15]
[PHENOTYPE-seizures-45]	[GENOTYPE-GABRA1-9]
[PHENOTYPE-seizures-41]	[GENOTYPE-GABRG2-13]
[PHENOTYPE-seizures-45]	[GENOTYPE-GABRD-15]
[PHENOTYPE-seizures-35]	[GENOTYPE-GABRA1-9]
[PHENOTYPE-seizures-45]	[GENOTYPE-GABRB3-11]
[PHENOTYPE-seizures-41]	[GENOTYPE-GABRA1-9]
[PHENOTYPE-seizures-41]	[GENOTYPE-GABRD-15]
[PHENOTYPE-seizures-35]	[GENOTYPE-GABRG2-13]
[PHENOTYPE-generalized epilepsy-38]	[GENOTYPE-GABRB3-11]
[PHENOTYPE-generalized epilepsy-38]	[GENOTYPE-GABRG2-13]
[PHENOTYPE-seizures-41]	[GENOTYPE-GABRB3-11]
[PHENOTYPE-seizures-45]	[GENOTYPE-GABRG2-13]
[PHENOTYPE-seizures-35]	[GENOTYPE-GABRD-15]
[PHENOTYPE-seizures-35]	[GENOTYPE-GABRB3-11]
PS472 Apparent mineralocorticoid excess is a syndrome of severe low - renin mineralocorticoid hypertension-13 associated with marked hypokalaemia-17 which arises from a congenital deficiency of 11 beta - Hydroxysteroid dehydrogenase-29 .
1
[PHENOTYPE-hypokalaemia-17]	[GENOTYPE-congenital deficiency of 11 beta - Hydroxysteroid dehydrogenase-29]
PS571 Mutations of the ATP7A gene-5 ( OMIM 300011 ) lead to the Menkes disease involving impaired brain development , neurological degeneration , connective tissue abnormalities , and high lethality in early infancy-32 .
0
PS577 Alport syndrome is a type IV collagen-7 hereditary disease characterized by progressive hematuric nephritis-14 , hearing loss-17 , and ocular changes .
2
[PHENOTYPE-hearing loss-17]	[GENOTYPE-type IV collagen-7]
[PHENOTYPE-nephritis-14]	[GENOTYPE-type IV collagen-7]
PS604 Germline mutations of a second cancer susceptibility gene BRCA1-9 ( ref . 5 ) , are associated with a strong predisposition to ovarian cancer-24 as well as female breast cancer-30 .
2
[PHENOTYPE-ovarian cancer-24]	[GENOTYPE-BRCA1-9]
[PHENOTYPE-breast cancer-30]	[GENOTYPE-BRCA1-9]
PS699 Alterations in tumour suppressor genes ( p53-7 , Rb-9 ) are associated instead with the most aggressive and poorly differentiated forms of thyroid cancer-24 , indicating that , in the thyroid tumourigenic process , they represent late genetic events .
2
[PHENOTYPE-thyroid cancer-24]	[GENOTYPE-Rb-9]
[PHENOTYPE-thyroid cancer-24]	[GENOTYPE-p53-7]
PS704 Complete achromatopsia-2 is a rare autosomal recessive disease associated with CNGA3-11 , CNGB3-13 , GNAT2-15 and PDE6C-17 mutations .
4
[PHENOTYPE-achromatopsia-2]	[GENOTYPE-GNAT2-15]
[PHENOTYPE-achromatopsia-2]	[GENOTYPE-PDE6C-17]
[PHENOTYPE-achromatopsia-2]	[GENOTYPE-CNGA3-11]
[PHENOTYPE-achromatopsia-2]	[GENOTYPE-CNGB3-13]
PS715 The allelic variants in the NOD2 / CARD15-8 gene G908R-10 , R702W-12 , and 1007fs are strongly and independently associated with susceptibility to Crohn ' s disease-27 .
4
[PHENOTYPE-Crohn ' s disease-27]	[GENOTYPE-NOD2 / CARD15-8]
[PHENOTYPE-Crohn ' s disease-27]	[GENOTYPE-1007fs]
[PHENOTYPE-Crohn ' s disease-27]	[GENOTYPE-R702W-12]
[PHENOTYPE-Crohn ' s disease-27]	[GENOTYPE-G908R-10]
PS723 Mutations in the CRB1 gene-5 are associated with variable phenotypes of severe retinal dystrophies-14 , ranging from leber congenital amaurosis to rod - cone dystrophy , also called retinitis pigmentosa-30 .
2
[PHENOTYPE-retinal dystrophies-14]	[GENOTYPE-CRB1 gene-5]
[PHENOTYPE-retinitis pigmentosa-30]	[GENOTYPE-CRB1 gene-5]
PS724 Moreover , retinal dystrophies-4 resulting from CRB1-7 mutations may be accompanied by specific fundus features : preservation of the para - arteriolar retinal pigment epithelium ( PPretinitis pigmentosaE-28 ) and retinal telangiectasia-32 with exudation ( also referred to as Coats - like vasculopathy-43 ) .
4
[PHENOTYPE-retinal dystrophies-4]	[GENOTYPE-CRB1-7]
[PHENOTYPE-vasculopathy-43]	[GENOTYPE-CRB1-7]
[PHENOTYPE-PPretinitis pigmentosaE-28]	[GENOTYPE-CRB1-7]
[PHENOTYPE-retinal telangiectasia-32]	[GENOTYPE-CRB1-7]
PS739 Mutations in Notch3 gene-4 are responsible for the cerebral autosomal dominant arteriopathy-12 with subcortical infarcts-15 and leukoencephalopathy-17 .
3
[PHENOTYPE-subcortical infarcts-15]	[GENOTYPE-Notch3 gene-4]
[PHENOTYPE-leukoencephalopathy-17]	[GENOTYPE-Notch3 gene-4]
[PHENOTYPE-arteriopathy-12]	[GENOTYPE-Notch3 gene-4]
PS762 Type I fibrinogen-3 deficiencies ( hypofibrinogenemia and afibrinogenemia-8 ) are rare congenital disorders characterized by low or unmeasurable plasma fibrinogen antigen-21 levels .
1
[PHENOTYPE-hypofibrinogenemia and afibrinogenemia-8]	[GENOTYPE-plasma fibrinogen antigen-21]
PS771 Both Glycogen storage disease type Ia and Glycogen storage disease type Ib patients manifest phenotypic glucose - 6 - phosphatase deficiency , characterized by growth retardation , hypoglycemia-28 , hepatomegaly-30 , nephromegaly-32 , hyperlipidemia-34 , hyperuricemia-36 , and lactic academia and the current treatment is a dietary therapy .
5
[PHENOTYPE-hyperuricemia-36]	[GENOTYPE-glucose - 6 - phosphatase deficiency]
[PHENOTYPE-nephromegaly-32]	[GENOTYPE-glucose - 6 - phosphatase deficiency]
[PHENOTYPE-hypoglycemia-28]	[GENOTYPE-glucose - 6 - phosphatase deficiency]
[PHENOTYPE-hyperlipidemia-34]	[GENOTYPE-glucose - 6 - phosphatase deficiency]
[PHENOTYPE-hepatomegaly-30]	[GENOTYPE-glucose - 6 - phosphatase deficiency]
PS804 R7V-1 is a seven - aminoacid peptide epitope derived from cellular beta - 2 microglobulin-15 , present on human immunodeficiency-20 virus virion surface in patients with human immunodeficiency-28 virus infection .
4
[PHENOTYPE-immunodeficiency-28]	[GENOTYPE-cellular beta - 2 microglobulin-15]
[PHENOTYPE-immunodeficiency-20]	[GENOTYPE-R7V-1]
[PHENOTYPE-immunodeficiency-28]	[GENOTYPE-R7V-1]
[PHENOTYPE-immunodeficiency-20]	[GENOTYPE-cellular beta - 2 microglobulin-15]
PS823 Mutations in two genes , Endoglin-6 and activin receptor - like kinase 1-13 ( ACVRL1-15 or ALK1-17 ) have been associated with hemorrhagic telangiectasia-24 .
4
[PHENOTYPE-hemorrhagic telangiectasia-24]	[GENOTYPE-ACVRL1-15]
[PHENOTYPE-hemorrhagic telangiectasia-24]	[GENOTYPE-activin receptor - like kinase 1-13]
[PHENOTYPE-hemorrhagic telangiectasia-24]	[GENOTYPE-Endoglin-6]
[PHENOTYPE-hemorrhagic telangiectasia-24]	[GENOTYPE-ALK1-17]
PS872 Similarly , in patients with Polycythaemia vera , homozygous as compared with heterozygous JAK2 ( V617F-16 ) correlated with higher levels of polycythaemia rubra vera - 1 expression ( P = 0 . 11 ) .
2
[PHENOTYPE-Polycythaemia vera]	[GENOTYPE-JAK2 ( V617F-16 )]
[PHENOTYPE-polycythaemia rubra vera - 1 expression]	[GENOTYPE-JAK2 ( V617F-16 )]
PS893 Several biochemical abnormalities have been postulated to play a role in the pathogenesis of the neurological changes in ARG1 deficiency including hyperargininemia-22 , elevated guanidino compounds and elevated glutamine levels , as well as the hyperammonemia-36 .
2
[PHENOTYPE-hyperammonemia-36]	[GENOTYPE-ARG1 deficiency]
[PHENOTYPE-hyperargininemia-22]	[GENOTYPE-ARG1 deficiency]
PS910 Carnitine palmitoyltransferase II deficiency is the most common lipid myopathy-10 in adults and is characterized by exercise - induced pain , stiffness , and myoglobinuria-25 .
1
[PHENOTYPE-myoglobinuria-25]	[GENOTYPE-Carnitine palmitoyltransferase II deficiency]
PS917 The correlation of atrophic gastritis and gastric cancer with a pepsinogen phenotype lacking pepsinogen A3 can be explained by loss of expression of pepsinogen A3 encoding genes-27 throughout the complete gastric mucosa .
1
[PHENOTYPE-gastric cancer with a pepsinogen phenotype lacking pepsinogen A3]	[GENOTYPE-loss of expression of pepsinogen A3 encoding genes-27]
PS919 The deregulation of ferritin-4 production responsible of Hereditary hyperferritinemia - cataract syndrome-12 is caused by heterogeneous mutations in the iron regulatory element of L - ferritin-26 that interfere with the binding of iron regulatory proteins , disrupting the negative control of L - ferritin-44 synthesis and causing the constitutive up - regulation of ferritin L - chains-57 .
4
[PHENOTYPE-hyperferritinemia - cataract syndrome-12]	[GENOTYPE-L - ferritin-26]
[PHENOTYPE-hyperferritinemia - cataract syndrome-12]	[GENOTYPE-ferritin L - chains-57]
[PHENOTYPE-hyperferritinemia - cataract syndrome-12]	[GENOTYPE-ferritin-4]
[PHENOTYPE-hyperferritinemia - cataract syndrome-12]	[GENOTYPE-L - ferritin-44]
PS925 tumor necrosis factor microsatellite alleles-5 were not related to the prevalences of bone erosion , rheumatoid nodule , sicca syndrome , pulmonary fibrosis-23 , and seropositivity of rheumatoid factor-29 in patients with rheumatoid arthritis-34 .
0
PS927 The association of tumor necrosis factorb6-6 with the susceptibility to rheumatoid arthritis-12 depends on the presence of HLA - DR4-20 , and the correlation of tumor necrosis factora9-28 to rheumatoid arthritis-31 depends on the absence of HLA - DR4-39 .
4
[PHENOTYPE-rheumatoid arthritis-31]	[GENOTYPE-HLA - DR4-39]
[PHENOTYPE-rheumatoid arthritis-12]	[GENOTYPE-tumor necrosis factorb6-6]
[PHENOTYPE-rheumatoid arthritis-12]	[GENOTYPE-HLA - DR4-20]
[PHENOTYPE-rheumatoid arthritis-31]	[GENOTYPE-tumor necrosis factora9-28]
PS929 Moreover , tumor necrosis factorb6-5 and HLA - DR4-9 have a synergistic effect on the susceptibility to rheumatoid arthritis-19 .
2
[PHENOTYPE-rheumatoid arthritis-19]	[GENOTYPE-tumor necrosis factorb6-5]
[PHENOTYPE-rheumatoid arthritis-19]	[GENOTYPE-HLA - DR4-9]
PS444 Tumor necrosis factora3 - e1-25 and tumor necrosis factor - 308A-31 have a synergistic effect on preventing from rheumatoid arthritis-40 .
2
[PHENOTYPE-rheumatoid arthritis-40]	[GENOTYPE-tumor necrosis factor - 308A-31]
[PHENOTYPE-rheumatoid arthritis-40]	[GENOTYPE-Tumor necrosis factora3 - e1-25]
PS939 Heterozygous GNAS inactivating mutations-4 are known to induce pseudohypoparathyroidism type 1a when maternally inherited and pseudopseudohypoparathyroidism-16 when paternally inherited .
2
[PHENOTYPE-pseudopseudohypoparathyroidism-16]	[GENOTYPE-GNAS inactivating mutations-4]
[PHENOTYPE-pseudohypoparathyroidism type 1a]	[GENOTYPE-GNAS inactivating mutations-4]
PS983 Mutations in the crumbs homologue 1 gene-7 cause a specific form of retinitis pigmentosa that is designated " retinitis pigmentosa12 " and is characterized by a preserved para - arteriolar retinal pigment epithelium ( PPretinitis pigmentosaE ) and by severe loss of vision at age < 20 years .
2
[PHENOTYPE-PPretinitis pigmentosaE]	[GENOTYPE-crumbs homologue 1 gene-7]
[PHENOTYPE-retinitis pigmentosa12]	[GENOTYPE-crumbs homologue 1 gene-7]
PS1002 The functional HSPB1 promoter - 1271G > C variant-9 may affect lung cancer-13 susceptibility and survival by modulating endogenous Heat - shock protein 27-24 synthesis levels .
2
[PHENOTYPE-cancer-13]	[GENOTYPE-Heat - shock protein 27-24]
[PHENOTYPE-cancer-13]	[GENOTYPE-HSPB1 promoter - 1271G > C variant-9]
PS1018 In regard to ApoE-4 , epsilon4 / epsilon4 genotype was absent in the Chilean population analyzed , and only the epsilon2 / epsilon4 genotype was significantly increased in both mild cognitive impairment-32 and Alzheimer ' s disease patients patients .
1
[PHENOTYPE-cognitive impairment-32]	[GENOTYPE-epsilon2 / epsilon4 genotype]
PS1061 Interaction of MEF2C-3 with the deleted febrile seizure-8 ( FEB4 ) and juveline myoclonic epilepsy ( EJM4 ) loci plus the G - protein receptor-25 ( GPR98-27 / MASS1-29 / Usher syndrome ) gene may moderate the phenotype , perhaps through common regulation by calcium .
4
[PHENOTYPE-seizure-8]	[GENOTYPE-GPR98-27]
[PHENOTYPE-seizure-8]	[GENOTYPE-G - protein receptor-25]
[PHENOTYPE-seizure-8]	[GENOTYPE-MASS1-29]
[PHENOTYPE-seizure-8]	[GENOTYPE-MEF2C-3]
PS1069 This study examines the relationship of genotype to phenotype in 14 unselected patients who were found to harbour the A3243G transition in the mitochondrial transfer RNALeu-26 ( UUR-28 ) gene commonly associated with the syndrome of mitochondrial encephalopathy-38 , lactic acidosis-41 and strokes-43 ( MELAS ) .
6
[PHENOTYPE-strokes-43]	[GENOTYPE-UUR-28]
[PHENOTYPE-mitochondrial encephalopathy-38]	[GENOTYPE-mitochondrial transfer RNALeu-26]
[PHENOTYPE-mitochondrial encephalopathy-38]	[GENOTYPE-UUR-28]
[PHENOTYPE-lactic acidosis-41]	[GENOTYPE-mitochondrial transfer RNALeu-26]
[PHENOTYPE-lactic acidosis-41]	[GENOTYPE-UUR-28]
[PHENOTYPE-strokes-43]	[GENOTYPE-mitochondrial transfer RNALeu-26]
PS1088 lipoprotein lipase S447X mutation-27 is associated with a higher risk of pancreatic calcification-36 and steatorrhea than those previously known factors in hyperlipidemic pancreatitis-46 patients .
2
[PHENOTYPE-hyperlipidemic pancreatitis-46]	[GENOTYPE-lipoprotein lipase S447X mutation-27]
[PHENOTYPE-pancreatic calcification-36]	[GENOTYPE-lipoprotein lipase S447X mutation-27]
PS1103 In summary , we show that the COX - 2 - 765 G allele promoter polymorphism-16 is significantly associated with gastric cancer-22 when compared with the normal control group , but does not appear to be related directly to COX - 2-42 expression pattern in gastric cancer-47 .
1
[PHENOTYPE-gastric cancer-22]	[GENOTYPE-COX - 2 - 765 G allele promoter polymorphism-16]
PS1140 The methods are applied to a study of the penetrance for breast cancer-13 of BRCA1-15 and BRCA2-17 mutations among Ashkenazi Jews .
2
[PHENOTYPE-breast cancer-13]	[GENOTYPE-BRCA2-17]
[PHENOTYPE-breast cancer-13]	[GENOTYPE-BRCA1-15]
PS1319 We describe a male infant with carnitine palmitoyltransferase 2-9 deficiency who presented with acute encephalopathy-15 related to human herpesvirus - 6 infection .
1
[PHENOTYPE-encephalopathy-15]	[GENOTYPE-carnitine palmitoyltransferase 2-9]
PS1330 PON1 status , which includes PON1 level as well as PON1192 genotype-12 , may be a better predictor for cardiovascular disease-21 or organophosphate susceptibility than PON1 genotype-27 alone .
1
[PHENOTYPE-cardiovascular disease-21]	[GENOTYPE-PON1192 genotype-12]
PS1348 Multiple Endocrine Neoplasia2-3 refers to the inherited forms of medullary thyroid carcinoma-12 which is associated with phaechromocytoma and parathyroid tumours in Multiple Endocrine Neoplasia2A , phaechromocytoma-26 and mucosal neuromas in Multiple Endocrine Neoplasia2B-33 .
3
[PHENOTYPE-Neoplasia2B-33]	[GENOTYPE-Endocrine Neoplasia2-3]
[PHENOTYPE-phaechromocytoma-26]	[GENOTYPE-Endocrine Neoplasia2-3]
[PHENOTYPE-thyroid carcinoma-12]	[GENOTYPE-Endocrine Neoplasia2-3]
PS1373 Patients with isolated hypodontia-4 caused by PAX9-7 or MSX1-9 mutation reported before May 2007 were enrolled .
2
[PHENOTYPE-hypodontia-4]	[GENOTYPE-PAX9-7]
[PHENOTYPE-hypodontia-4]	[GENOTYPE-MSX1-9]
PS1398 Analyses that took into account confounding factors confirmed the negative association of hemoglobin C-14 with malaria-16 attack ( P = 0 . 0074 ) and evidenced a negative correlation between hemoglobin C-32 and parasitemia-34 ( P = 0 . 0009 ) .
4
[PHENOTYPE-parasitemia-34]	[GENOTYPE-hemoglobin C-14]
[PHENOTYPE-malaria-16]	[GENOTYPE-hemoglobin C-32]
[PHENOTYPE-malaria-16]	[GENOTYPE-hemoglobin C-14]
[PHENOTYPE-parasitemia-34]	[GENOTYPE-hemoglobin C-32]
PS1445 The risk of therapeutic failure-5 after chloroquine was increased by the presence of pfcrt K76T ( Day 28 , odds ratio = 7 . 2 [ 95 % CI : 4 . 5 - 11 . 5 ] ) , pfmdr1 N86Y-42 was associated with both chloroquine ( Day 28 , odds ratio = 1 . 8 [ 95 % CI : 1 . 3 - 2 . 4 ] ) and amodiaquine failures-74 ( odds ratio = 5 . 4 [ 95 % CI : 2 . 6 - 11 . 3 , p < 0 . 001 ] ) .
1
[PHENOTYPE-amodiaquine failures-74]	[GENOTYPE-pfmdr1 N86Y-42]
PS1486 To test the hypothesis that polymorphisms of ESR1-8 , the gene encoding estrogen receptor alpha-15 , are associated with susceptibility , clinical phenotype , and progression of breast cancer-29 .
2
[PHENOTYPE-breast cancer-29]	[GENOTYPE-polymorphisms of ESR1-8]
[PHENOTYPE-breast cancer-29]	[GENOTYPE-estrogen receptor alpha-15]
PS1487 Frequencies of single - nucleotide polymorphismss were compared between cases and controls to identify single - nucleotide polymorphismss associated with cancer-21 susceptibility and between cases with different clinical phenotypes to determine the role of ESR1 polymorphism in cancer-38 progression .
2
[PHENOTYPE-cancer-38]	[GENOTYPE-ESR1 polymorphism]
[PHENOTYPE-cancer-21]	[GENOTYPE-ESR1 polymorphism]
PS1492 Multiple endocrine neoplasia-3 type 2 is caused by autosomal dominant gain - of - function mutations in the RET proto - oncogene-22 , which includes multiple endocrine neoplasia-34 type 2A , type 2B ( MEN 2B ) , and familial medullary thyroid carcinoma-50 .
3
[PHENOTYPE-neoplasia-34]	[GENOTYPE-RET proto - oncogene-22]
[PHENOTYPE-neoplasia-3]	[GENOTYPE-RET proto - oncogene-22]
[PHENOTYPE-thyroid carcinoma-50]	[GENOTYPE-RET proto - oncogene-22]
PS1541 A review of all published mutations suggests that mutation in the C - terminal coiled coil region or truncation of the tailpiece is associated with haematological - only phenotype , while mutation of the head ATPase domain-37 frequently is associated with nephropathy-42 and / or hearing loss-47 .
2
[PHENOTYPE-nephropathy-42]	[GENOTYPE-head ATPase domain-37]
[PHENOTYPE-hearing loss-47]	[GENOTYPE-head ATPase domain-37]
PS1597 Haploinsufficiency of a more proximal region , located on 10p13 - 10p14-12 , designated as DGCR2-16 is associated with congenital heart defects-22 and thymus hypoplasia-25 / aplasia or T cell defect .
2
[PHENOTYPE-congenital heart defects-22]	[GENOTYPE-DGCR2-16]
[PHENOTYPE-hypoplasia-25]	[GENOTYPE-DGCR2-16]
PS1629 Although both Juvenile polyposis-4 and Juvenile polyposis - hemorrhagic telangiectasia-10 are caused by SMAD4 mutations-15 , a possible genotype : phenotype correlation was noted as all of the SMAD4 mutations-30 in the Juvenile polyposis - hemorrhagic telangiectasia patients were clustered in the COOH - terminal MH2 domain of the protein .
2
[PHENOTYPE-polyposis-4]	[GENOTYPE-SMAD4 mutations-15]
[PHENOTYPE-telangiectasia-10]	[GENOTYPE-SMAD4 mutations-15]
PS1650 There was significant phenotypic variability , but the presence of skeletal muscle involvement ( p < 0 . 001 ) , supraventricular arrhythmia-23 ( p = 0 . 003 ) , conduction defects ( p = 0 . 01 ) , and " mildly " dilated cardiomyopathy-47 ( p = 0 . 006 ) were predictors of lamin A / C gene mutations-63 .
2
[PHENOTYPE-dilated cardiomyopathy-47]	[GENOTYPE-lamin A / C gene mutations-63]
[PHENOTYPE-supraventricular arrhythmia-23]	[GENOTYPE-lamin A / C gene mutations-63]
PS1669 The polymorphisms rs9858542 ( BSN ) and rs3197999-8 ( MST1 ) , on 3p21 locus , have been found associated with susceptibility to inflammatory bowel disease-26 .
2
[PHENOTYPE-inflammatory bowel disease-26]	[GENOTYPE-rs9858542]
[PHENOTYPE-inflammatory bowel disease-26]	[GENOTYPE-rs3197999-8]
PS1686 In conclusion , SMN2 alleles-5 are not functionally equivalent among Spinal muscular atrophy-13 patients , although in general the SMN2-20 copy number is correlated with the severity of Spinal muscular atrophy-31 .
2
[PHENOTYPE-Spinal muscular atrophy-31]	[GENOTYPE-SMN2-20]
[PHENOTYPE-Spinal muscular atrophy-13]	[GENOTYPE-SMN2 alleles-5]
PS1688 Human leukocyte antigen - DQB1 alleles-60 are associated with susceptibility or resistance to Gastric cancer-69 and also influence its clinical features .
1
[PHENOTYPE-susceptibility or resistance to Gastric cancer-69]	[GENOTYPE-human leukocyte antigen - DQB1 alleles-60]
PS1718 In conclusion , human leukocyte antigen - DQB1 ( * ) 0602 confers susceptibility to gastric cancer-17 , especially for male Taiwanese and proximal tumor location , while human leukocyte antigen - DQB1 ( * ) 0301 may have a protective effect on Gastric cancer-45 , probably through resistance to Helicobacter pylori infection . 
2
[PHENOTYPE-gastric cancer-17]	[GENOTYPE-human leukocyte antigen - DQB1 ( * ) 0602 ]
[PHENOTYPE-Gastric cancer-45]	[GENOTYPE-human leukocyte antigen - DQB1 ( * ) 0301]
PS1755 Mutations of the Cu / Zn superoxide dismutase gene-9 ( SOD1-11 ) are responsible for 20 % of autosomal dominant familial Amyotrophic lateral sclerosis-24 .
2
[PHENOTYPE-Amyotrophic lateral sclerosis-24]	[GENOTYPE-Cu / Zn superoxide dismutase gene-9]
[PHENOTYPE-Amyotrophic lateral sclerosis-24]	[GENOTYPE-SOD1-11]
PS1796 In the pediatric cohort the associations of TNFSF15-8 , NKX2 - 3-12 with Crohn ' s disease , and PTGER4-20 , NKX2 - 3-24 , ZNF365-26 , IFNG-28 , PSMG1-30 with ulcerative colitis-33 , were confirmed .
5
[PHENOTYPE-ulcerative colitis-33]	[GENOTYPE-ZNF365-26]
[PHENOTYPE-ulcerative colitis-33]	[GENOTYPE-NKX2 - 3-24]
[PHENOTYPE-ulcerative colitis-33]	[GENOTYPE-PTGER4-20]
[PHENOTYPE-ulcerative colitis-33]	[GENOTYPE-PSMG1-30]
[PHENOTYPE-ulcerative colitis-33]	[GENOTYPE-IFNG-28]
PS1803 We report a novel mutation of the factor VII gene-10 that creates the amino acid change Ser 103 to Gly , which resulted in severe factor VII-27 deficiency with reduced factor VII antigen-33 .
2
[PHENOTYPE-reduced factor VII antigen-33]	[GENOTYPE-factor VII-27]
[PHENOTYPE-reduced factor VII antigen-33]	[GENOTYPE-factor VII gene-10]
PS1866 In neuroblastoma-2 , N - myc amplification and loss of heterozygosity for the short arm-15 of chromosome 1 ( LOH 1p ) are common genetic abnormalities .
2
[PHENOTYPE-neuroblastoma-2]	[GENOTYPE-N - myc amplification]
[PHENOTYPE-neuroblastoma-2]	[GENOTYPE-N - chromosome 1 ( LOH 1p )]
PS1916 We replicated the genetic association with rs13277113 ( p = 0 . 0009 , OR 1 . 46 ) and rs2736340 ( p = 0 . 0001 , OR 1 . 63 ) from C8orf13 - BLK-37 ( 8p23 . 1-41 , associated with rheumatoid arthritis-46 and systemic lupus erythematosus-50 ) , and rs763361 ( p = 0 . 03 ) from CD226-63 ( 18q22 . 3-67 , associated with multiple sclerosis-72 and type 1 diabetes ) in the Colombian population .
6
[PHENOTYPE-systemic lupus erythematosus-50]	[GENOTYPE-C8orf13 - BLK-37]
[PHENOTYPE-rheumatoid arthritis-46]	[GENOTYPE-8p23 . 1-41]
[PHENOTYPE-rheumatoid arthritis-46]	[GENOTYPE-C8orf13 - BLK-37]
[PHENOTYPE-multiple sclerosis-72]	[GENOTYPE-CD226-63]
[PHENOTYPE-multiple sclerosis-72]	[GENOTYPE-18q22 . 3-67]
[PHENOTYPE-systemic lupus erythematosus-50]	[GENOTYPE-8p23 . 1-41]
PS1917 Our results demonstrate that the IL2 / IL21-8 region , C8orf13 - BLK-13 , and CD226-16 influence rheumatoid arthritis-19 in Colombians , and rheumatoid arthritis-25 shares some of the pathogenic mechanisms associated with other autoimmune diseases-36 .
3
[PHENOTYPE-rheumatoid arthritis-19]	[GENOTYPE-IL2 / IL21-8 region]
[PHENOTYPE-rheumatoid arthritis-19]	[GENOTYPE-C8orf13 - BLK-13]
[PHENOTYPE-rheumatoid arthritis-19]	[GENOTYPE-CD226-16]
PS1947 We have previously shown that the c1 / c1-9 genotype recognized by Rsa I-14 in the 5 ' - regulatory region of the cytochrome P4502E1-25 may be a susceptibility factor for developing esophageal cancer-34 and lung cancer-37 in Chinese .
4
[PHENOTYPE-lung cancer-37]	[GENOTYPE-cytochrome P4502E1-25]
[PHENOTYPE-lung cancer-37]	[GENOTYPE-c1 / c1-9]
[PHENOTYPE-esophageal cancer-34]	[GENOTYPE-cytochrome P4502E1-25]
[PHENOTYPE-esophageal cancer-34]	[GENOTYPE-c1 / c1-9]
PS1962 Mutations in the Aristaless - related homeobox gene-8 are associated with a wide variety of neurologic disorders including lissencephaly , hydrocephaly-21 , West syndrome , Partington syndrome , and X - linked intellectual disability-34 with or without epilepsy .
2
[PHENOTYPE-X - linked intellectual disability-34]	[GENOTYPE-Mutations in the Aristaless - related homeobox gene-8]
[PHENOTYPE-hydrocephaly-21]	[GENOTYPE-Mutations in the Aristaless - related homeobox gene-8]
PS2029 Abnormal FOXP3 expression results in defective regulatory functions of T cells , which in turn cause a systemic T - cell - mediated autoaggressive disorder-25 , now called immune dysregulation , polyendocrinopathy autoimmune enteropathy X - linked syndrome .
2
[PHENOTYPE-polyendocrinopathy autoimmune enteropathy X - linked syndrome]	[GENOTYPE-Abnormal FOXP3 expression]
[PHENOTYPE-T - cell - mediated autoaggressive disorder-25]	[GENOTYPE-Abnormal FOXP3 expression]
PS2037 Familial hypercholesterolemia-2 , characterized by isolated elevation of plasmatic low - density lipoprotein cholesterol and premature coronary heart disease , is associated with mutations in three major genes : low - density lipoprotein receptor-34 , apolipoprotein B and proprotein convertase subtilisin / kexin 9-44 .
2
[PHENOTYPE-Familial hypercholesterolemia-2]	[GENOTYPE-apolipoprotein B and proprotein convertase subtilisin / kexin 9-44]
[PHENOTYPE-Familial hypercholesterolemia-2]	[GENOTYPE-low - density lipoprotein receptor-34]
PS2043 Large deletions including the TWIST gene-6 have been identified in some patients with learning disabilities-15 or mental retardation-18 , which are not typically part of the Saethre - Chotzen syndrome .
2
[PHENOTYPE-learning disabilities-15]	[GENOTYPE-TWIST gene-6]
[PHENOTYPE-mental retardation-18]	[GENOTYPE-TWIST gene-6]
PS2050 Since glycosylated hemoglobin-3 is found inside red blood cells , the relationship between RH genetic variability and Hb A ( 1c ) level suggests that RH proteins-27 may influence glucose transport through red cell membrane and / or hemoglobin glycation-40 .
1
[PHENOTYPE-glycation-40]	[GENOTYPE-RH proteins-27]
PS2071 In multiple sclerosis-3 patients confirmed as Arylsulfatase A - PD mutations carriers , arylsulfatase-14 activity was determined in leukocyte homogenates by spectrophotometry .
2
[PHENOTYPE-multiple sclerosis-3]	[GENOTYPE-arylsulfatase-14]
[PHENOTYPE-multiple sclerosis-3]	[GENOTYPE-Arylsulfatase A - PD mutations]
PS2085 A good correlation was observed between enhanced lung cancer-9 risk and restriction fragment length polymorphisms of the P450IA1 gene-19 with the restriction enzyme MspI-24 .
1
[PHENOTYPE-lung cancer-9]	[GENOTYPE-P450IA1 gene-19]
PS2090 The germline mutations in GATA4-5 , NKX2 . 5-9 , and TFAP2B genes-13 have been identified to be responsible for congenital heart disease-23 .
3
[PHENOTYPE-congenital heart disease-23]	[GENOTYPE-NKX2 . 5-9]
[PHENOTYPE-congenital heart disease-23]	[GENOTYPE-TFAP2B genes-13]
[PHENOTYPE-congenital heart disease-23]	[GENOTYPE-GATA4-5]
PS2093 RESULTS : Fifteen heterozygous mutations in the GATA4 gene-9 were identified in 30 congenital heart disease-16 patients , including a novel heterozygous missense mutation ( c . 788 C > G ) of GATA4-34 in one patient with ventricular septal defect-41 .
2
[PHENOTYPE-congenital heart disease-16]	[GENOTYPE-mutations in the GATA4 gene-9]
[PHENOTYPE-ventricular septal defect-41]	[GENOTYPE-missense mutation ( c . 788 C > G ) of GATA4-34]
PS2097 A sequence variant ( rs7216389 - T ) near the ORMDL3 gene-12 on chromosome 17q21 was recently found to be associated with childhood asthma-24 .
1
[PHENOTYPE-asthma-24]	[GENOTYPE-sequence variant ( rs7216389 - T ) near the ORMDL3 gene-12]
PS2099 Thus , the contribution of rs7216389 - T-8 to the development of asthma-13 is unlikely to operate only through an impact on the expression of ORMDL3-26 or GSDMB genes-29 .
1
[PHENOTYPE-asthma-13]	[GENOTYPE-rs7216389 - T-8]
PS2175 Mutations in SLC3A1-3 , which encodes rBAT , cause Type I cystinuria-12 , and mutations in SLC7A9-17 , which encodes a putative subunit of rBAT-25 ( b ( o , + ) AT ) , cause non - Type I cystinuria-41 .
3
[PHENOTYPE-non - Type I cystinuria-41]	[GENOTYPE-SLC7A9-17]
[PHENOTYPE-non - Type I cystinuria-41]	[GENOTYPE-rBAT-25]
[PHENOTYPE-Type I cystinuria-12]	[GENOTYPE-SLC3A1-3]
PS2188 Matrix metalloproteinase - 3-4 is implicated in the formation of atherosclerotic plaques , and the Matrix metalloproteinase - 3 - 1612 5A / 6A-24 polymorphism is associated with myocardial infarction-30 and stable coronary artery disease-35 .
2
[PHENOTYPE-myocardial infarction-30]	[GENOTYPE-Matrix metalloproteinase - 3 - 1612 5A / 6A-24]
[PHENOTYPE-coronary artery disease-35]	[GENOTYPE-Matrix metalloproteinase - 3 - 1612 5A / 6A-24]
PS2323 Even though the VEGFD gene-5 was interrupted by the X ; 9 translocation , it seems unlikely that VEGFD-19 is causing the translocation patient ' s Hypomagnesemia-27 with secondary hypocalcemia - like phenotype-33 .
0
PS2325 Polymorphism of A1166C gene of type 1 vascular receptor of angiotensin II ( AGTR1 ) contributes to formation of arterial hypertension-21 signs diversity in diabetes mellitus-26 type 2 patients .
2
[PHENOTYPE-diabetes mellitus-26]	[GENOTYPE-Polymorphism of A1166C gene of type 1 vascular receptor of angiotensin II ( AGTR1 )]
[PHENOTYPE-arterial hypertension-21]	[GENOTYPE-Polymorphism of A1166C gene of type 1 vascular receptor of angiotensin II ( AGTR1 )]
PS2329 Primary dysfunction of Phenylalanine hydroxylase-5 caused by mutations in the Phenylalanine hydroxylase gene-13 results in hyperphenylalaninemia-16 , which may impair cognitive development unless corrected by dietary restriction of phenylalanine .
1
[PHENOTYPE-hyperphenylalaninemia-16]	[GENOTYPE-Primary dysfunction of Phenylalanine hydroxylase-5 ]
PS2340 As rare 18q interstitial deletions affecting multiple genes including SET binding protein 1 gene-14 correlate with a milder phenotype , including minor physical anomalies and developmental and expressive speech delay-30 , mutations in SET binding protein 1 gene-38 are thought to result in a gain - of - function or a dominant - negative effect .
1
[PHENOTYPE-speech delay-30]	[GENOTYPE-SET binding protein 1 gene-14]
PS2358 We have shown that the combination of the additional mutations H208Y , R211K , and L214F-16 in human immunodeficiency virus type 1 reverse transcriptase may influence Zidovudine resistance-28 and should be considered when assessing Zidovudine resistance .
2
[PHENOTYPE-Zidovudine resistance-28]	[GENOTYPE-combination of the additional mutations H208Y , R211K , and L214F-16]
[PHENOTYPE-Zidovudine resistance-28]	[GENOTYPE-human immunodeficiency virus type 1 reverse transcriptase-24]
PS2416 These results suggest that susceptibility to arylamine - induced bladder cancer-11 might be influenced by both hepatic and bladder N - acetyltransferase-22 and that the N - acetyltransferase-28 genotype might be a useful biomarker for screening high risk individuals for bladder cancer-42 resulting from exposure to arylamines .
2
[PHENOTYPE-bladder cancer-42]	[GENOTYPE-N - acetyltransferase-28]
[PHENOTYPE-bladder cancer-11]	[GENOTYPE-bladder N - acetyltransferase-22]
PS2431 The polymorphisms LTA rs1041981-4 and LGALS2 rs7291467-7 were associated with coronary stenosis-12 index with odds ratios of 1 . 54 ( 95 % CI , 1 . 17 - 2 . 01 ; AA + CA over CC ) and 1 . 62 ( 95 % CI , 1 . 11 - 2 . 37 ; TT over CC + CT ) , respectively .
2
[PHENOTYPE-coronary stenosis-12]	[GENOTYPE-LGALS2 rs7291467-7]
[PHENOTYPE-coronary stenosis-12]	[GENOTYPE-polymorphisms LTA rs1041981-4]
PS2362 Proteasome subunit a type 6 rs1048990-71 was not associated with coronary stenosis index .
0
PS2469 Germline RET proto - oncogene mutations are the genetic causes of multiple endocrine neoplasia-14 type 2 and a strong genotype - phenotype correlation exists , particularly between a specific RET codon mutation-32 and the ( a ) age - related onset and ( b ) thyroid tumor progression , from C - cell hyperplasia-54 to medullary thyroid carcinoma-58 and , ultimately , to nodal metastases .
6
[PHENOTYPE-thyroid carcinoma-58]	[GENOTYPE-RET codon mutation-32]
[PHENOTYPE-multiple endocrine neoplasia-14]	[GENOTYPE-RET codon mutation-32]
[PHENOTYPE-thyroid carcinoma-58]	[GENOTYPE-Germline RET proto - oncogene mutations]
[PHENOTYPE-C - cell hyperplasia-54]	[GENOTYPE-RET codon mutation-32]
[PHENOTYPE-C - cell hyperplasia-54]	[GENOTYPE-Germline RET proto - oncogene mutations]
[PHENOTYPE-multiple endocrine neoplasia-14]	[GENOTYPE-Germline RET proto - oncogene mutations]
PS2502 The homozygosity of M694V mutation in the MEFV gene-9 is associated with arthritis-13 in Familial Mediterranean fever-17 patients .
1
[PHENOTYPE-arthritis-13]	[GENOTYPE-M694V mutation in the MEFV gene-9]
PS2519 Achondrogenesis II - hypochondrogenesis and severe spondyloepiphyseal dysplasia congenita-9 are lethal forms of dwarfism-14 caused by dominant mutations in the type II collagen gene ( COL2A1 ) .
2
[PHENOTYPE-dwarfism-14]	[GENOTYPE-mutations in the type II collagen gene-24 ( COL2A1 )]
[PHENOTYPE-spondyloepiphyseal dysplasia congenita-9]	[GENOTYPE-mutations in the type II collagen gene-24 ( COL2A1 )]
PS2526 Auditory and vestibulo - ocular functions were examined in a Dutch family with autosomal dominantly inherited sensorineural hearing impairment-19 caused by a 208C > T mutation in the COCH gene , located in chromosome 14q12 - q13 ( DFNA9 ) .
1
[PHENOTYPE-hearing impairment-19]	[GENOTYPE-a 208C > T mutation in the COCH gene , located in chromosome 14q12 - q13 ( DFNA9 )]
PS2536 Recent studies have implicated that the rs11614913 SNP in miR - 196a2-12 may be associated with susceptibility to lung cancer-20 , congenital heart disease-24 , breast cancer-27 , as well as reduced survival in non - small cell lung cancer-40 .
4
[PHENOTYPE-lung cancer-20]	[GENOTYPE-the rs11614913 SNP in miR - 196a2-12]
[PHENOTYPE-breast cancer-27]	[GENOTYPE-the rs11614913 SNP in miR - 196a2-12]
[PHENOTYPE-congenital heart disease-24]	[GENOTYPE-the rs11614913 SNP in miR - 196a2-12]
[PHENOTYPE-non - small cell lung cancer-40]	[GENOTYPE-the rs11614913 SNP in miR - 196a2-12]
PS2590 Endothelin - B receptor-4 ( EDNRB-6 ) signaling pathway is associated for Hirschsprung disease-14 .
2
[PHENOTYPE-Hirschsprung disease-14]	[GENOTYPE-EDNRB-6]
[PHENOTYPE-Hirschsprung disease-14]	[GENOTYPE-Endothelin - B receptor-4]
PS2637 We previously reported a familial G504S mutation in the type II collagen-12 ( COL2A1-14 ) gene resulting in Spondyloepiphyseal dysplasia-20 congenita .
2
[PHENOTYPE-Spondyloepiphyseal dysplasia-20]	[GENOTYPE-COL2A1-14]
[PHENOTYPE-Spondyloepiphyseal dysplasia-20]	[GENOTYPE-type II collagen-12]
PS2648 Severe pancreatic insufficiency-3 was associated with the presence of two Cystic fibrosisTR gene mutations-14 ( DeltaF508-16 , N1303K-18 , Cystic fibrosisTR dele 2-23 , 3 ( 21kb ) , G542X , 1717 - 1G - A , R533X , W1282X , 621GT , 2183AAG , R560T , 2184insA and DeltaI507 , G551D , 895T ) and mild insufficiency with the presence of at least one mutation ( R117H , 3171insC , A155P2 , 138insL , 296 + 1G - A , E92GK , E217G , 2789 + 5G - A . 3849 + 1kbC - T / 3849 + 1kbC - T ) genotype resulted in high elastase - 1 - values-112 .
5
[PHENOTYPE-pancreatic insufficiency-3]	[GENOTYPE-high elastase - 1 - values-112]
[PHENOTYPE-pancreatic insufficiency-3]	[GENOTYPE-Cystic fibrosisTR gene mutations-14]
[PHENOTYPE-pancreatic insufficiency-3]	[GENOTYPE-DeltaF508-16]
[PHENOTYPE-pancreatic insufficiency-3]	[GENOTYPE-N1303K-18]
[PHENOTYPE-pancreatic insufficiency-3]	[GENOTYPE-Cystic fibrosisTR dele 2-23]
PS2650 OTX2 mutations are associated with severe ocular phenotypes and central nervous system abnormalities such as seizures-16 , short stature-19 and developmental delay , combined pituitary hormone deficiency-27 , structural abnormalities of the pituitary gland and early onset retinal dystrophy-39 .
4
[PHENOTYPE-seizures-16]	[GENOTYPE-OTX2 mutations]
[PHENOTYPE-short stature-19]	[GENOTYPE-OTX2 mutations]
[PHENOTYPE-pituitary hormone deficiency-27]	[GENOTYPE-OTX2 mutations]
[PHENOTYPE-retinal dystrophy-39]	[GENOTYPE-OTX2 mutations]
PS2651 P450c17 deficiency ( 17OHD ) , caused by mutation in CYP17A1 gene-12 , is characterized by severe hypertension - hypokalemia-20 , sexual infantilism in females , and pseudohermaphroditism-28 in males .
2
[PHENOTYPE-pseudohermaphroditism-28]	[GENOTYPE-mutation in CYP17A1 gene-12]
[PHENOTYPE-hypertension - hypokalemia-20]	[GENOTYPE-mutation in CYP17A1 gene-12]
PS2658 Congenital erythropoietic porphyria-3 is a rare inborn error of metabolism that results from a deficient activity of uroporphyrinogen III synthase-20 ( URO - synthase-24 ) .
2
[PHENOTYPE-erythropoietic porphyria-3]	[GENOTYPE-uroporphyrinogen III synthase-20]
[PHENOTYPE-erythropoietic porphyria-3]	[GENOTYPE-URO - synthase-24]
PS2687 X - linked myotubular myopathy-5 is a severe neuromuscular disease of infancy caused by mutations of myotubular myopathy1-18 , which encodes the phosphoinositide lipid phosphatase-25 , myotubularin .
2
[PHENOTYPE-myopathy-5]	[GENOTYPE-phosphoinositide lipid phosphatase-25]
[PHENOTYPE-myopathy-5]	[GENOTYPE-mutations of myotubular myopathy1-18]
PS2704 In patients with chronic systolic heart failure-7 , the chymase - 1 polymorphism was related to nonischemic etiology of heart failure-21 .
1
[PHENOTYPE-heart failure-21]	[GENOTYPE-chymase - 1 polymorphism]
PS2740 Regarding unique symptoms in each case , congenital fibrosis-9 of the extraocular muscles found only in Case 1 may be caused by KIF21A deletion and hearing loss-27 and cleft palate-30 in Case 2 by COL2A1 defect .
3
[PHENOTYPE-cleft palate-30]	[GENOTYPE-COL2A1 defect]
[PHENOTYPE-hearing loss-27]	[GENOTYPE-COL2A1 defect]
[PHENOTYPE-congenital fibrosis-9]	[GENOTYPE-KIF21A deletion]
PS2763 Association studies have reported that common single - nucleotide polymorphisms in KCNE1-12 and SCN5A-14 may predispose to Atrial fibrillation-19 .
2
[PHENOTYPE-Atrial fibrillation-19]	[GENOTYPE-SCN5A-14]
[PHENOTYPE-Atrial fibrillation-19]	[GENOTYPE-KCNE1-12]
PS2771 Heterozygous missense mutations of transient receptor potential vanilloid 4 channel-10 cause a spectrum of skeletal disorders , including brachyolmia-19 , spondylometaphyseal dysplasia-22 Kozlowski type , metatropic dysplasia-27 , parastremmatic dysplasia , and spondyloepimetaphyseal dysplasia Maroteaux type .
3
[PHENOTYPE-spondylometaphyseal dysplasia-22]	[GENOTYPE-vanilloid 4 channel-10]
[PHENOTYPE-metatropic dysplasia-27]	[GENOTYPE-vanilloid 4 channel-10]
[PHENOTYPE-brachyolmia-19]	[GENOTYPE-vanilloid 4 channel-10]
PS2827 Mutations in the skeletal muscle alpha - actin gene ( ACTA1-11 ) cause a range of pathologically defined congenital myopathies-20 .
2
[PHENOTYPE-congenital myopathies-20]	[GENOTYPE-Mutations in the skeletal muscle alpha - actin gene]
[PHENOTYPE-congenital myopathies-20]	[GENOTYPE-ACTA1-11]
PS2839 There was also a significant correlation between p21-8 ( waf-10 ) loss and chronic active hepatitis ( P = 0 . 01 ) as well as between mdm2-28 , c - erbB2-32 and cirrhosis-34 ( P = 0 . 025 and 0 . 001 ) in hepatocellular carcinoma-48 cases .
2
[PHENOTYPE-cirrhosis-34]	[GENOTYPE-c - erbB2-32]
[PHENOTYPE-cirrhosis-34]	[GENOTYPE-mdm2-28]
PS2846 Mutations in FGFR1-3 and TWIST1-5 have been reported to affect the timing of calvarial suture fusion resulting in craniosynostosis-19 and facial abnormalities-22 .
4
[PHENOTYPE-craniosynostosis-19]	[GENOTYPE-FGFR1-3]
[PHENOTYPE-craniosynostosis-19]	[GENOTYPE-TWIST1-5]
[PHENOTYPE-facial abnormalities-22]	[GENOTYPE-FGFR1-3]
[PHENOTYPE-facial abnormalities-22]	[GENOTYPE-TWIST1-5]
PS2931 Hereditary cystathioninuria-2 is presumed to be caused by deficiency of the activity of cystathionine gamma - lyase-17 ( cystathionase-19 ; CTH EC 4 . 4 . 1 . 1-29 ) , which is normally required for the conversion of methionine into cysteine .
3
[PHENOTYPE-cystathioninuria-2]	[GENOTYPE-CTH EC 4 . 4 . 1 . 1-29]
[PHENOTYPE-cystathioninuria-2]	[GENOTYPE-deficiency of the activity of cystathionine gamma - lyase-17]
[PHENOTYPE-cystathioninuria-2]	[GENOTYPE-cystathionase-19]
PS2934 Polymorphic expression of arylamine N-acetyltransferase ( EC 2 . 3 . 1 . 5 ) may be a differential risk factor in metabolic activation of arylamine carcinogens and susceptibility to cancers related to arylamine exposures.
1
[PHENOTYPE-cancers]	[GENOTYPE-Polymorphic expression of arylamine N-acetyltransferase ( EC 2 . 3 . 1 . 5 )]
PS2959 Moreover , high - density lipoprotein cholesterol decrease-8 is not associated with elevated levels of LDL cholesterol-17 ( r = - 0 . 20 , NS ) , which is the primary characteristic feature of familial hypercholesterolemia-37 subjects .
1
[PHENOTYPE-familial hypercholesterolemia-37]	[GENOTYPE-LDL cholesterol-17]
PS2989 Defects in the ryanodine receptor-5 ( RYR1-7 ) gene are associated with malignant hyperthermia-14 , an autosomal dominant disorder of skeletal muscle and one of the main causes of death resulting from anaesthesia-33 .
2
[PHENOTYPE-malignant hyperthermia-14]	[GENOTYPE-ryanodine receptor-5]
[PHENOTYPE-malignant hyperthermia-14]	[GENOTYPE-RYR1-7]
PS3009 Mutations in the high penetrance breast and ovarian cancer susceptibility gene BRCA1-12 account for a significant percentage of hereditary breast-20 and ovarian cancer-23 cases .
2
[PHENOTYPE-breast-20]	[GENOTYPE-BRCA1-12]
[PHENOTYPE-ovarian cancer-23]	[GENOTYPE-BRCA1-12]
PS3033 Carbonic anhydrase II deficiency syndrome characterized by osteopetrosis-8 , renal tubular acidosis-12 , and cerebral calcifications-16 is caused by mutations in the carbonic anhydrase 2-25 gene .
3
[PHENOTYPE-renal tubular acidosis-12]	[GENOTYPE-mutations in the carbonic anhydrase 2-25]
[PHENOTYPE-cerebral calcifications-16]	[GENOTYPE-mutations in the carbonic anhydrase 2-25]
[PHENOTYPE-osteopetrosis-8]	[GENOTYPE-mutations in the carbonic anhydrase 2-25]
PS3041 The association of the rare hereditary cancer syndrome , multiple endocrine neoplasia type 2a with Hirschsprung ' s disease-19 , both linked to germline mutations in the RET proto - oncogene-31 , has been reported recently .
2
[PHENOTYPE-multiple endocrine neoplasia type 2a with Hirschsprung ' s disease-19]	[GENOTYPE-mutations in the RET proto - oncogene-31]
[PHENOTYPE-rare hereditary cancer syndrome]	[GENOTYPE-mutations in the RET proto - oncogene-31]
PS3047 In conclusion , childhood obesity-5 contributes to higher plasminogen activator inhibitor - 1-13 and tumor necrosis factor - alpha-19 and lower transforming growth factor beta-25 levels .
3
[PHENOTYPE-obesity-5]	[GENOTYPE-tumor necrosis factor - alpha-19]
[PHENOTYPE-obesity-5]	[GENOTYPE-lower transforming growth factor beta-25]
[PHENOTYPE-obesity-5]	[GENOTYPE-higher plasminogen activator inhibitor - 1-13]
PS3050 Dyschromatosis symmetrica hereditaria is an autosomal dominant pigmentary genodermatosis characterized by hyperpigmented and hypopigmented macules-15 of on the extremities and caused by the mutations in the ADAR gene-28 ( also called DSRAD-32 ) encoding for RNA - specific adenosine deaminase-40 .
6
[PHENOTYPE-hypopigmented macules-15]	[GENOTYPE-RNA - specific adenosine deaminase-40]
[PHENOTYPE-Dyschromatosis symmetrica hereditaria]	[GENOTYPE-DSRAD-32]
[PHENOTYPE-hypopigmented macules-15]	[GENOTYPE-DSRAD-32]
[PHENOTYPE-Dyschromatosis symmetrica hereditaria]	[GENOTYPE-ADAR gene-28]
[PHENOTYPE-hypopigmented macules-15]	[GENOTYPE-ADAR gene-28]
[PHENOTYPE-Dyschromatosis symmetrica hereditaria]	[GENOTYPE-RNA - specific adenosine deaminase-40]
PS3051 Heterozygous germline mutations of the tumor - suppressor gene multiple endocrine neoplasia type 1-14 are responsible for multiple endocrine neoplasia-20 type 1 , a dominantly inherited familial cancer-28 syndrome characterized by pituitary , parathyroid , and enteropancreatic tumors-38 .
3
[PHENOTYPE-enteropancreatic tumors-38]	[GENOTYPE-endocrine neoplasia type 1-14]
[PHENOTYPE-cancer-28]	[GENOTYPE-endocrine neoplasia type 1-14]
[PHENOTYPE-neoplasia-20]	[GENOTYPE-endocrine neoplasia type 1-14]
PS3100 In conclusion , Angiotensin - converting enzyme-7 activity , but not Angiotensin - converting enzyme-15 polymorphisms , was associated with the degree of myocardial hypertrophy-25 in the patients with hypertrophic cardiomyopathy-31 .
2
[PHENOTYPE-hypertrophic cardiomyopathy-31]	[GENOTYPE-Angiotensin - converting enzyme-7]
[PHENOTYPE-myocardial hypertrophy-25]	[GENOTYPE-Angiotensin - converting enzyme-7]
PS3107 Activating mutations of the p110 alpha subunit of PI3K ( PIK3CA ) oncogene-13 have been identified in a broad spectrum of malignant tumors-23 .
1
[PHENOTYPE-malignant tumors-23]	[GENOTYPE-p110 alpha subunit of PI3K ( PIK3CA ) oncogene-13]
PS3109 For instance , mutations of the gsp-7 and thyroid - stimulating hormone receptor genes-14 are associated with benign hyperfunctioning thyroid nodules and adenomas while alterations of other specific genes , such as oncogenic tyrosine kinase-35 alterations ( RET-38 / PTC-40 , TRK-42 ) in papillary carcinoma-46 and the newly discovered PAX8-51 / peroxisome proliferator - activated receptor gamma-58 rearrangement , are distinctive features of cancer-65 .
10
[PHENOTYPE-cancer-65]	[GENOTYPE-PAX8-51]
[PHENOTYPE-cancer-65]	[GENOTYPE-RET-38]
[PHENOTYPE-cancer-65]	[GENOTYPE-TRK-42]
[PHENOTYPE-papillary carcinoma-46]	[GENOTYPE-TRK-42]
[PHENOTYPE-papillary carcinoma-46]	[GENOTYPE-RET-38]
[PHENOTYPE-papillary carcinoma-46]	[GENOTYPE-oncogenic tyrosine kinase-35]
[PHENOTYPE-cancer-65]	[GENOTYPE-PTC-40]
[PHENOTYPE-cancer-65]	[GENOTYPE-oncogenic tyrosine kinase-35]
[PHENOTYPE-cancer-65]	[GENOTYPE-peroxisome proliferator - activated receptor gamma-58]
[PHENOTYPE-papillary carcinoma-46]	[GENOTYPE-PTC-40]
PS3179 Genetic mutations resulting in decreased neuronal Na ( + ) , K ( + ) - ATPase-17 ( sodium - potassium adenosine triphosphatase-23 ) activity may put individuals at risk for depression-32 given that decreased Na ( + ) , K ( + ) - ATPase-46 activity is observed in depressive disorders-52 and animal models of depression-57 .
4
[PHENOTYPE-depressive disorders-52]	[GENOTYPE-decreased Na ( + ) , K ( + ) - ATPase-46]
[PHENOTYPE-depression-57]	[GENOTYPE-decreased Na ( + ) , K ( + ) - ATPase-46]
[PHENOTYPE-depression-32]	[GENOTYPE-decreased neuronal Na ( + ) , K ( + ) - ATPase-17]
[PHENOTYPE-depression-32]	[GENOTYPE-sodium - potassium adenosine triphosphatase-23]
PS3205 FOXP1-1 was more highly expressed in familial breast cancers-9 compared with sporadic cancers-13 for luminal ( p = 0 . 021 ) and basal ( p < 0 . 001 ) , but not HER2-35 and null phenotypes ( both p > 0 . 05 ) .
4
[PHENOTYPE-breast cancers-9]	[GENOTYPE-HER2-35]
[PHENOTYPE-sporadic cancers-13]	[GENOTYPE-HER2-35]
[PHENOTYPE-breast cancers-9]	[GENOTYPE-FOXP1-1]
[PHENOTYPE-sporadic cancers-13]	[GENOTYPE-FOXP1-1]
PS3221 Variants in HTRA1-3 , CFH-5 , and C2-8 were also associated with polypoidal choroidal vasculopathy-15 .
3
[PHENOTYPE-polypoidal choroidal vasculopathy-15]	[GENOTYPE-C2-8]
[PHENOTYPE-polypoidal choroidal vasculopathy-15]	[GENOTYPE-HTRA1-3]
[PHENOTYPE-polypoidal choroidal vasculopathy-15]	[GENOTYPE-CFH-5]
PS3309 Malignant hyperthermia-2 is associated , in the majority of cases , with mutations in RYR1-15 , the gene encoding the skeletal muscle ryanodine receptor-24 .
2
[PHENOTYPE-Malignant hyperthermia-2]	[GENOTYPE-skeletal muscle ryanodine receptor-24]
[PHENOTYPE-Malignant hyperthermia-2]	[GENOTYPE-mutations in RYR1-15]
PS3329 Parasitic worm infection , allergy and asthma-7 involve increased IgE-10 production , eosinophil activity , mucus secretion and smooth muscle reactivity , effected through Th - 2-27 immune signalling .
2
[PHENOTYPE-asthma-7]	[GENOTYPE-Th - 2-27]
[PHENOTYPE-asthma-7]	[GENOTYPE-IgE-10]
PS3609 In addition , we identified several CAPN10 alleles-8 associated to phenotypic differences observed between polycystic ovaries-16 patients , such as the presence of hypercholesterolemia-24 ( haplotype 1121 , P = 0 . 005 ) , presence of hyperandrogenic features ( P = 0 . 05 ) , and familial cancer-50 incidence ( haplotype 1111 , P = 0 . 0005 ) .
2
[PHENOTYPE-hypercholesterolemia-24]	[GENOTYPE-CAPN10 alleles-8]
[PHENOTYPE-cancer-50]	[GENOTYPE-CAPN10 alleles-8]
PS3405 Some of the severe ( the majority of patients affected with either the severe form ) spinal muscular atrophy-19 cases correlated with the extent of deletions in the SMN-29 , NAIP-31 and P44 genes-34 or the dosage of SMN gene-40 when both SMN1-43 and SMN2-45 are deleted .
6
[PHENOTYPE-spinal muscular atrophy-19]	[GENOTYPE-SMN-29]
[PHENOTYPE-spinal muscular atrophy-19]	[GENOTYPE-SMN2-45]
[PHENOTYPE-spinal muscular atrophy-19]	[GENOTYPE-SMN gene-40]
[PHENOTYPE-spinal muscular atrophy-19]	[GENOTYPE-P44 genes-34]
[PHENOTYPE-spinal muscular atrophy-19]	[GENOTYPE-SMN1-43]
[PHENOTYPE-spinal muscular atrophy-19]	[GENOTYPE-NAIP-31]
PS3434 Mutations in the gene encoding filaggrin-6 have been identified as the cause of ichthyosis vulgaris-15 and have been shown to be major predisposing factors for atopic eczema-27 , initially in European populations .
2
[PHENOTYPE-ichthyosis vulgaris-15]	[GENOTYPE-Mutations in the gene encoding filaggrin-6]
[PHENOTYPE-atopic eczema-27]	[GENOTYPE-Mutations in the gene encoding filaggrin-6]
PS3449 Mucopolysaccharidosis type VI is an autosomal recessive lysosomal storage disease caused by a deficiency of N - acetylgalactosamine - 4 - sulphatase-22 ( arylsulfatase B-25 , ASB-27 ) .
3
[PHENOTYPE-Mucopolysaccharidosis type VI]	[GENOTYPE-N - deficiency of N - acetylgalactosamine - 4 - sulphatase-22]
[PHENOTYPE-Mucopolysaccharidosis type VI]	[GENOTYPE-arylsulfatase B-25]
[PHENOTYPE-Mucopolysaccharidosis type VI]	[GENOTYPE-ASB-27]
PS3454 Mucopolysaccharidosis VI is a rare autosomal recessive disorder caused by a deficiency of N - acetylgalactosamine - 4 - sulfatase-20 ( ARSB-22 ) .
2
[PHENOTYPE-Mucopolysaccharidosis VI]	[GENOTYPE-ARSB-22]
[PHENOTYPE-Mucopolysaccharidosis VI]	[GENOTYPE-deficiency of N - acetylgalactosamine - 4 - sulfatase-20]
PS3485 The causative gene for JPrimary lateral sclerosis-7 was found to be ALS2-12 , which is also responsible for a recessive form of amyotrophic lateral sclerosis-25 , for infantile onset ascending hereditary spastic paralysis-33 and for a form of complicated hereditary spastic paraplegia-42 .
4
[PHENOTYPE-JPrimary lateral sclerosis-7]	[GENOTYPE-ALS2-12]
[PHENOTYPE-spastic paralysis-33]	[GENOTYPE-ALS2-12]
[PHENOTYPE-spastic paraplegia-42]	[GENOTYPE-ALS2-12]
[PHENOTYPE-amyotrophic lateral sclerosis-25]	[GENOTYPE-ALS2-12]
PS3573 Interleukin - 6-3 , an inflammatory cytokine , is thought to play a role in neurodegeneration of the central nervous system and has been associated with increased amyloid precursor protein-30 expression in vitro and greater cognitive decline-37 .
1
[PHENOTYPE-cognitive decline-37]	[GENOTYPE-Interleukin - 6-3]
PS3585 Mutations in the skeletal muscle alpha - actin gene-9 ( ACTA1-11 ) associated with congenital myopathy-16 with excess of thin myofilaments , nemaline myopathy-24 and intranuclear rod myopathy-28 were first described in 1999 .
6
[PHENOTYPE-congenital myopathy-16]	[GENOTYPE-ACTA1-11]
[PHENOTYPE-nemaline myopathy-24]	[GENOTYPE-Mutations in the skeletal muscle alpha - actin gene-9]
[PHENOTYPE-nemaline myopathy-24]	[GENOTYPE-ACTA1-11]
[PHENOTYPE-intranuclear rod myopathy-28]	[GENOTYPE-ACTA1-11]
[PHENOTYPE-congenital myopathy-16]	[GENOTYPE-Mutations in the skeletal muscle alpha - actin gene-9]
[PHENOTYPE-intranuclear rod myopathy-28]	[GENOTYPE-Mutations in the skeletal muscle alpha - actin gene-9]
